A critical review on the translational journey of cardioprotective therapies!

Related Experiment Video

Updated: Sep 30, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 6, 2016

8.8K

Xavier Rossello1, Derek M Yellon2

  • 1The Hatter Cardiovascular Institute, University College London, London, United Kingdom.

International Journal of Cardiology
|July 6, 2016
PubMed

Insights

Translating cardioprotective therapies to patients faces challenges in pre-clinical studies, surrogate validation, and clinical trial design. Addressing these gaps is crucial for improving outcomes after myocardial infarction (STEMI).

Area of Science:

  • Cardiology
  • Translational Medicine
  • Pharmacology

Background:

  • Novel cardioprotective therapies often fail to translate from pre-clinical research to clinical practice.
  • This failure impacts patient outcomes, particularly in managing post-ST-elevation myocardial infarction (STEMI) heart failure and cardiovascular death rates.

Purpose of the Study:

  • To review the evidence and identify critical gaps in the translational pathway of cardioprotective interventions.
  • To highlight areas for improvement to enhance the successful clinical application of these therapies.

Main Methods:

  • Literature review focusing on the translational journey of cardioprotective therapies.
  • Classification of identified gaps into three main categories: pre-clinical studies, surrogate validation, and clinical trial design.

Main Results:

  • Gaps exist in pre-clinical study methodologies and validation processes.
  • The utility of infarct size as a reliable surrogate endpoint requires further validation.
  • Challenges are present in the design and interpretation of randomized clinical trials for cardioprotection.

Conclusions:

  • Addressing identified gaps in research and clinical trial design is essential for successful translation.
  • Improving the translational success of cardioprotective therapies can significantly reduce post-STEMI heart failure and cardiovascular mortality.
Keywords:
Ischemia–reperfusion injuryOutcomes researchST-segment elevation myocardial infarction

More Related Videos

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft08:30

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft

Published on: February 13, 2022

3.1K
In Silico Clinical Trials for Cardiovascular Disease09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 26, 2022

2.2K

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...